Legal & General Group PLC Pulse Biosciences, Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 15,695 shares of PLSE stock, worth $226,008. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,695

Previous 22,415 29.98%

Holding current value

$226,008

Previous $338,000 18.34%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$14.52 - $18.52 $97,574 - $124,454	-6,720 Reduced 29.98%	15,695 $276,000
Q2 2025 Aug 12, 2025	BUY	$14.48 - $19.27 $118,692 - $157,956	8,197 Added 57.65%	22,415 $338,000
Q1 2025 May 15, 2025	SELL	$15.61 - $24.56 $63,766 - $100,327	-4,085 Reduced 22.32%	14,218 $228,000
Q4 2024 Feb 13, 2025	BUY	$14.56 - $21.08 $51,265 - $74,222	3,521 Added 23.82%	18,303 $338,000
Q3 2024 Feb 28, 2025	SELL	$10.83 - $21.83 $38,132 - $76,863	-3,521 Reduced 19.24%	14,782 $259,000

Q3 2024 Nov 14, 2024	BUY	$10.83 - $21.83 $135,829 - $273,791	12,542 Added 559.91%	14,782 $259,000
Q2 2024 May 29, 2025	BUY	$6.69 - $14.54 $5,298 - $11,515	792 Added 54.7%	2,240 $25,000
Q2 2024 Aug 14, 2024	BUY	$6.69 - $14.54 $5,298 - $11,515	792 Added 54.7%	2,240 $25,000
Q1 2024 May 29, 2025	SELL	$7.8 - $11.02 $99,606 - $140,725	-12,770 Reduced 89.82%	1,448 $12,000
Q4 2023 May 29, 2025	SELL	$3.85 - $12.84 $49,164 - $163,966	-12,770 Reduced 89.82%	1,448 $17,000
Q4 2023 Feb 15, 2024	SELL	$3.85 - $12.84 $411 - $1,373	-107 Reduced 6.88%	1,448 $17,000
Q2 2023 Aug 14, 2023	BUY	$3.67 - $8.64 $5,706 - $13,435	1,555 New	1,555 $11,000
Q2 2022 Aug 22, 2022	SELL	$1.48 - $4.28 $2,271 - $6,569	-1,535 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.21 - $14.79 $349 - $1,227	83 Added 5.72%	1,535 $7,000
Q3 2021 Nov 15, 2021	SELL	$17.25 - $26.63 $1,138 - $1,757	-66 Reduced 4.35%	1,452 $31,000
Q1 2021 May 17, 2021	SELL	$22.43 - $44.27 $3,700 - $7,304	-165 Reduced 9.8%	1,518 $36,000
Q3 2020 Nov 13, 2020	SELL	$9.27 - $13.14 $4,013 - $5,689	-433 Reduced 20.46%	1,683 $20,000
Q2 2020 Aug 14, 2020	BUY	$6.23 - $13.09 $2,236 - $4,699	359 Added 20.43%	2,116 $22,000
Q1 2020 May 14, 2020	SELL	$5.23 - $15.2 $2,227 - $6,475	-426 Reduced 19.51%	1,757 $13,000
Q4 2019 Feb 13, 2020	BUY	$12.58 - $15.97 $4,956 - $6,292	394 Added 22.02%	2,183 $29,000
Q2 2018 Aug 10, 2018	BUY	$14.04 - $20.28 $673 - $973	48 Added 2.76%	1,789 $27,000
Q1 2018 May 17, 2018	SELL	$12.67 - $24.69 $7,323 - $14,270	-578 Reduced 24.92%	1,741 $24,000
Q4 2017 Feb 13, 2018	BUY	$18.81 - $30.33 $43,620 - $70,335	2,319	2,319 $55,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

5.76M

Call Options Held

29.4K

Put Options Held

24K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $535M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Pulse Biosciences, Inc. Transaction History